Pharmacogenomics in Hypertension

Pharmacogenomics considerations in the control of hypertension.

Discussed In Paper More information · Ace Inhibitors, Plain · Angiotensin II Antagonists · Beta Blocking Agents · Calcium channel blockers · diuretics ...

Pharmacogenomics of Hypertension in Africa: Paving the Way for a ...

Genes implicated in the pharmacogenetics of hypertension were identified in reported African genomic studies (Ta- bles 4 and 5) and are ...

Pharmacogenomics of antihypertensive drugs

Pharmacogenomics of antihypertensive drugs: Rationale and design of the Pharmacogenomic. Evaluation of Antihypertensive Responses (PEAR) study. Julie A ...

A genome-wide, placebo-controlled cross-over study, using four ...

Pharmacogenomics of hypertension: A genome-wide, placebo-controlled cross-over study, using four classes of antihypertensive drugs · Overview · Fingerprint ...

Hypertension pharmacogenomics: current status and future directions.

Hypertension pharmacogenomics holds tremendous potential for providing a mechanism by which management of hypertensive patients might be improved, ...

a genome‐wide, placebo‐controlled cross‐over study, using four ...

Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugs. Journal of the American ...

Pharmacogenomics of hypertension: a realizable goal?

Pharmacogenomics of hypertension: a realizable goal? It is common clinical experience that individual patients vary in their response to different types of ...

Pharmacogenomics considerations in the control of hypertension

In spite of the efforts and the great number of publications, pharmacogenomics of antihypertensive drugs is far from being used in clinical ...

Pharmacogenomics in hypertension - Preprints.org

There are multiple choices of drugs and drug classes to treat hypertension, and yet the rate of successful blood pressure control is ...

PHARMACOGENOMICS-GUIDED DRUG THERAPY FOR ...

The hypertension control rate is only 16.8% in China, and superior reasonable treatment is contributive to improve the rate. This study is aimed ...

Pharmacogenomics of Hypertension Treatment - OUCI

Hypertension is one of the strongest modifiable cardiovascular risk factors, affecting an increasing number of people worldwide. Apart from poor medication ...

(PDF) Pharmacogenomics And Hypertension: Current Insights

To address the effects of genetic polymorphisms on blood pressure responses to the antihypertensive drug classes, studies have applied candidate ...

Exploring Pharmacogenetic Testing for Hypertension Management ...

Back Article ; [7], Schwartz GL, Turner ST. Pharmacogenetics of antihypertensive drug responses. Am J Pharmacogenomics 2004;4(3):151 − 60. http://dx.doi.org/ ...

Pharmacogenomics and hypertension: Current insights - Mendeley

To address the effects of genetic polymorphisms on blood pressure responses to the antihypertensive drug classes, studies have applied candidate genes and ...

The Pharmacogenomics of Anti-Hypertensive Therapy - MDPI

Hypertension pharmacogenomics seeks to find genetic predictors of response to drugs that lower blood pressure and to translate this knowledge into clinical ...

Pharmacogenomics of Hypertension and Preeclampsia

Similarly, a large number of patients with preeclampsia are non-responsive to antihypertensive therapy. Pharmacogenomics may help to guide the ...

Pharmacogenetics: Therapeutic regimen in hypertension

Pharmacogenetics in hypertension is a growing field that seeks to personalize the treatment of this common cardiovascular condition. By ...

Pharmacogenomic studies of hypertension

Hypertension Pharmacogenomics of hydro-chlorothiazide (MIHYPHCTZ), the Campania Salute ... Antihypertensive; blood pressure; pharmacogenomics ...

Hypertension pharmacogenomics - Enlighten Publications

Hypertension is the most important modifiable risk factor for cardiovascular disease. Despite the plethora of effective pharmacological ...

Pharmacogenomics and the Concept of Personalized Medicine for ...

Antihypertensive pharmacogenomics research aims to improve cardiovascular disease (CVD) outcomes in treated hypertensive patients by identifying ...